Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (QIV)
Classification:
Products in the Pipeline
- Product Description
- Immunogenicity
- Security
- Mad Dog Bite Cases
-
Manufacturing Process
The project employs the world mainstream technology of culturing influenza viruses in chicken embryos, whose unique harvesting and purification technologies effectively reduces impurities with the quality standard significantly higher than the requirements of Chinese Pharmacopoeia (Ch.P).
Current Progress
QIV has entered the Phase III clinical trial, and the production workshop has been commissioned.
Other Products
Inactivated Japanese Encephalitis Vaccine for Human Use (Vero cell) (IJEV)
SPEEDA-Rabies Vaccine for Human Use (Vero cell) (CPRV)
Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried (HDCV)
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (QIV)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV 13)
Recombinant Human Papillomavirus 15-valent Vaccine (Escherichia. Coli) (HPV 15)
Follow us
Telephone
Marketing Center
International Trade
Medical Consultation
Address
No.1, XinFang Street, Hunnan New District, Shenyang City
123456789
12456789